Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jul. 31, 2025	Jan. 31, 2025
Current assets
Cash and cash equivalents	$ 322,702	$ 186,331
Short-term investments	1,200,309	518,813
Accounts receivable, net of allowances of $389 and $499	217,048	177,627
Deferred commissions	97,216	91,919
Prepaid expenses and other current assets	91,696	102,951
Total current assets	1,928,971	1,077,641
Noncurrent assets
Property and equipment, net	58,335	53,194
Deferred commissions, noncurrent	125,416	132,465
Goodwill	194,531	100,343
Other assets, noncurrent	81,454	59,331
Total assets	2,388,707	1,422,974
Current liabilities
Accounts payable	13,983	10,439
Accrued expenses and other current liabilities	148,834	162,602
Deferred revenue	897,676	777,135
Total current liabilities	1,060,493	950,176
Deferred revenue, noncurrent	687,757	642,370
Other liabilities, noncurrent	76,254	61,821
Convertible senior notes, net	1,128,547	0
Debt, noncurrent	0	322,341
Total liabilities	2,953,051	1,976,708
Commitments and contingencies (Note 9)
Stockholders’ deficit
Preferred stock, $0.000025 par value – $20,000,000 shares authorized as of July 31, 2025 and January 31, 2025; zero shares issued and outstanding as of July 31, 2025 and January 31, 2025	0	0
Additional paid-in capital	2,473,597	2,291,829
Accumulated other comprehensive loss	(2,580)	(8,235)
Accumulated deficit	(3,035,366)	(2,837,333)
Total stockholders’ deficit	(564,344)	(553,734)
Total liabilities and stockholders’ deficit	2,388,707	1,422,974
Class A
Stockholders’ deficit
Common stock	4	3
Class B
Stockholders’ deficit
Common stock	$ 1	$ 2